tiprankstipranks
Stock Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksStock ScreenerCompare StocksPenny Stock ScreenerTop Product Insights Stocks
Daily Updates
Daily Analyst RatingsTrending StocksTop Stock GainersTop Stock LosersMost Active StocksDividend StocksChatGPT Stocks
New
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarMarket Holidays
ETF Research Tools
ETF CenterETF ScreenerTop ETFs by Smart Score
New
Compare ETFsTop ETFs by AUM
ETFs On the Move
Top ETF GainersTop ETF LosersMost Active ETFs
ETF Ideas
S&P 500 Index ETFsNasdaq 100 Index ETFsS&P 500 Sector ETFsBond ETFsCommodity ETFsCurrency ETFsIndustry ETFs
Best Dividend StocksBest High Yield Dividend StocksDividend Aristocrats
New
Dividend Stock ComparisonDividend Calculator
Popular
Dividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
My PortfolioMy WatchlistMy PerformanceMy Portfolio AnalysisCrowd Insights
Stock Market NewsStock Analysis & Ideas
Popular
ETF NewsGlobal Markets NewsExpert SpotlightTipRanks LabsEarnings Reports InsightsMarket BreakdownsDividend Stock NewsCrypto News
Education
TipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityCareersContact Us
Working with TipRanks
Enterprise SolutionsBest Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert Center
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stock Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Stock Screener
Compare Stocks
Penny Stock Screener
Top Product Insights Stocks
Options Profit Calculator
New
Daily Updates
Daily Analyst Ratings
Trending Stocks
Top Stock Gainers
Top Stock Losers
Most Active Stocks
Dividend Stocks
ChatGPT Stocks
New
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Market Holidays
ETF Research Tools
ETF Center
ETF Screener
New
Top ETFs by Smart Score
New
Compare ETFs
Top ETFs by AUM
ETFs On the Move
Top ETF Gainers
Top ETF Losers
Most Active ETFs
ETF Ideas
S&P 500 Index ETFs
Nasdaq 100 Index ETFs
S&P 500 Sector ETFs
Bond ETFs
Commodity ETFs
Currency ETFs
Industry ETFs
Best Dividend Stocks
Best High Yield Dividend Stocks
Dividend Aristocrats
New
Dividend Stock Comparison
Dividend Calculator
Popular
Dividend Returns Comparison
Dividend Calendar
Crypto Center
Bitcoin
Ethereum
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
My Portfolio
My Watchlist
My Performance
My Portfolio Analysis
Crowd Insights
Stock Market News
Stock Analysis & Ideas
Popular
ETF News
Global Markets News
Expert Spotlight
TipRanks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
Education
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Careers
Contact Us
Working with TipRanks
Enterprise Solutions
Best Online Brokers
Become an Affiliate
Follow Us
Plans & Pricing

EIGR Stock Latest News

Eiger BioPharmaceuticals Reports First Quarter 2023 Financial Results and Provides Business Update
Press ReleasesEiger BioPharmaceuticals Reports First Quarter 2023 Financial Results and Provides Business Update
25d ago
EIGR
EIGR Earnings this Week: How Will it Perform?
Pre-EarningsEIGR Earnings this Week: How Will it Perform?
28d ago
EIGR
Eiger BioPharmaceuticals appoints William Kachioff as CFO
The FlyEiger BioPharmaceuticals appoints William Kachioff as CFO
2M ago
EIGR
Warren, Ocasio-Cortez send letters to SVB depositors, Bloomberg reports
The FlyWarren, Ocasio-Cortez send letters to SVB depositors, Bloomberg reports
2M ago
BILL
EIGR
Eiger BioPharmaceuticals reports Q4 EPS (57c), consensus (54c)
The FlyEiger BioPharmaceuticals reports Q4 EPS (57c), consensus (54c)
3M ago
EIGR
Eiger BioPharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
Press ReleasesEiger BioPharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
3M ago
EIGR
Eiger BioPharmaceuticals announces publication of TOGETHER study data in NEJM
The FlyEiger BioPharmaceuticals announces publication of TOGETHER study data in NEJM
4M ago
EIGR
Biotech Alert: Searches spiking for these stocks today
The FlyBiotech Alert: Searches spiking for these stocks today
5M ago
ACHV
CLLS
Axsome Therapeutics named Top Pick for first half of 2023 at BTIG
The FlyAxsome Therapeutics named Top Pick for first half of 2023 at BTIG
5M ago
AXSM
EIGR
Eiger BioPharmaceuticals director buys $128K in common stock
The FlyEiger BioPharmaceuticals director buys $128K in common stock
5M ago
EIGR
Eiger BioPharmaceuticals CEO David Cory resigns, David Apelian named Interim CEO
The FlyEiger BioPharmaceuticals CEO David Cory resigns, David Apelian named Interim CEO
6M ago
EIGR
Biotech Alert: Searches spiking for these stocks today
The FlyBiotech Alert: Searches spiking for these stocks today
6M ago
NVS
ADMA
Eiger BioPharmaceuticals price target lowered to $9 from $48 at BTIG
The FlyEiger BioPharmaceuticals price target lowered to $9 from $48 at BTIG
6M ago
EIGR
Eiger BioPharmaceuticals price target lowered to $3 from $29 at Baird
The FlyEiger BioPharmaceuticals price target lowered to $3 from $29 at Baird
6M ago
EIGR
Eiger BioPharmaceuticals price target lowered to $4 from $23 at Citi
The FlyEiger BioPharmaceuticals price target lowered to $4 from $23 at Citi
6M ago
EIGR
Eiger Biopharmaceuticals Plunges 70% on New Phase 3 Data
Market NewsEiger Biopharmaceuticals Plunges 70% on New Phase 3 Data
6M ago
EIGR
Eiger BioPharma’s lonafarnib meets endpoints in Phase 3 HDV trial
The FlyEiger BioPharma’s lonafarnib meets endpoints in Phase 3 HDV trial
6M ago
EIGR
Eiger BioPharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update
Press ReleasesEiger BioPharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update
7M ago
EIGR
Eiger BioPharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update
Press ReleasesEiger BioPharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update
10M ago
EIGR
Eiger Pops 12% On FDA Approval For First Hutchinson-Gilford Progeria Treatment
Market NewsEiger Pops 12% On FDA Approval For First Hutchinson-Gilford Progeria Treatment
3y ago
EIGR
Billionaire David Shaw Pours Money Into 3 “Strong Buy” Stocks
Stock Analysis & IdeasBillionaire David Shaw Pours Money Into 3 “Strong Buy” Stocks
3y ago
EIGR
PRTK